Company intelligence / Profile preview

PraNa Biosciences

Southborough, Massachusetts, United Statespranabiosciences.com ↗

Ownership: Private
Development stage: Preclinical

Overview

The company has conducted at least one clinical trial for a celecoxib 100mg capsule bioequivalence study (CTRI/2021/02/031211) that was in the 'Not yet recruiting' status as of the last update.

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: Antibodies (mAbs)Biobetters
Industry: Biotech

Beyond the preview

Go deeper on PraNa Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PraNa Biosciences.

Explore the full profile